SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (20956)5/16/1998 11:39:00 PM
From: Machaon  Read Replies (8) | Respond to of 32384
 
<< The company recently completed Phase III trials for Panretin Gel, a treatment for AIDS lesions, and plans to file a new drug application by the end of the quarter, while Targretin has shown early promise in breast-cancer therapies. >>

Nice coverage. We need more of this. Let's hope we get good news coverage out of the ASCO conference! We need the word Ligand to become more of a household word.

Regards, Bob